INS and type 2 diabetes mellitus: Activation of melatonin signaling in β-cells (with a duration designed to mimic typical nightly exposure) significantly enhances the cAMP-dependent signal transduction pathway and attenuates β-cell oxidative stress and apoptosis [13] restoring glucose-stimulated and incretin-stimulated insulin secretion in islets isolated from subjects with T2DM [13].